Eterna Therapeutics Stock Forecast - Triple Exponential Smoothing
| ERNA Stock | USD 1.90 0.07 3.83% |
The Triple Exponential Smoothing forecasted value of Eterna Therapeutics on the next trading day is expected to be 1.89 with a mean absolute deviation of 0.1 and the sum of the absolute errors of 5.71. Eterna Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Eterna Therapeutics stock prices and determine the direction of Eterna Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Eterna Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Eterna Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Eterna Therapeutics' systematic risk associated with finding meaningful patterns of Eterna Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Eterna Therapeutics to cross-verify your projections. Eterna |
Most investors in Eterna Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Eterna Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Eterna Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Triple exponential smoothing for Eterna Therapeutics - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Eterna Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Eterna Therapeutics price movement. However, neither of these exponential smoothing models address any seasonality of Eterna Therapeutics. Eterna Therapeutics Triple Exponential Smoothing Price Forecast For the 4th of June
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Eterna Therapeutics on the next trading day is expected to be 1.89 with a mean absolute deviation of 0.1, mean absolute percentage error of 0.02, and the sum of the absolute errors of 5.71.Please note that although there have been many attempts to predict Eterna Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eterna Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eterna Therapeutics Stock Forecast Pattern
| Backtest Eterna Therapeutics | Eterna Therapeutics Price Prediction | Buy or Sell Advice |
Eterna Therapeutics Forecasted Value
In the context of forecasting Eterna Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eterna Therapeutics' downside and upside margins for the forecasting period are 0.02 and 7.16, respectively. We have considered Eterna Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Eterna Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Eterna Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.018 |
| MAD | Mean absolute deviation | 0.0968 |
| MAPE | Mean absolute percentage error | 0.0461 |
| SAE | Sum of the absolute errors | 5.7132 |
Predictive Modules for Eterna Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eterna Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eterna Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Eterna Therapeutics
For every potential investor in Eterna, whether a beginner or expert, Eterna Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eterna Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eterna. Basic forecasting techniques help filter out the noise by identifying Eterna Therapeutics' price trends.View Eterna Therapeutics Related Equities
| Risk & Return | Correlation |
Eterna Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eterna Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eterna Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eterna Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Eterna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eterna Therapeutics shares will generate the highest return on investment. By undertsting and applying Eterna Therapeutics stock market strength indicators, traders can identify Eterna Therapeutics entry and exit signals to maximize returns.
Eterna Therapeutics Risk Indicators
The analysis of Eterna Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eterna Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eterna stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.16 | |||
| Semi Deviation | 4.31 | |||
| Standard Deviation | 5.66 | |||
| Variance | 32.08 | |||
| Downside Variance | 23.44 | |||
| Semi Variance | 18.53 | |||
| Expected Short fall | (5.37) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Eterna Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eterna Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eterna Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eterna Therapeutics Stock:Check out Historical Fundamental Analysis of Eterna Therapeutics to cross-verify your projections. For information on how to trade Eterna Stock refer to our How to Trade Eterna Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Eterna Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eterna Therapeutics. If investors know Eterna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eterna Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.25) | Revenue Per Share 0.013 | Return On Assets (0.36) | Return On Equity (3.02) |
The market value of Eterna Therapeutics is measured differently than its book value, which is the value of Eterna that is recorded on the company's balance sheet. Investors also form their own opinion of Eterna Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Eterna Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eterna Therapeutics' market value can be influenced by many factors that don't directly affect Eterna Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eterna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eterna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eterna Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.